Background: Much of the research examining psychosocial aspects of genetic testing has used hypothetical scenarios, based on the largely untested assumption that hypothetical genetic testing intentions are good proxies for behavior. We tested whether hypothetical interest predicts uptake of genetic testing and whether factors that predict interest also predict uptake. Methods: Participants (n = 116) were smokers and related to patients with lung cancer, who completed a telephone survey. Interest in genetic testing for lung cancer risk was indicated by responding ‘definitely would’ to a Likert-style question. Internet-delivered genetic testing for lung cancer risk was then offered. Uptake was indicated by requesting the test and receiving the result. Results: 63% of participants said they ‘definitely would’ take the genetic test; uptake was 38%. Participants who said they ‘definitely would’ take the test were more likely than others to take the offered test (45% vs. 26%, p = 0.035). Interest was associated with attitudes towards genetic testing and motivation to quit smoking. Uptake was associated with motivation, prior awareness of genetic testing, and daily Internet use. Conclusion: Hypothetical interest only modestly predicts uptake of genetic testing. Interest in genetic testing likely reflects generally positive attitudes that are not good predictors of the choices individuals subsequently make.

Keywords:
Attitudes, Complex diseases, Decision-making, Evaluation of genetic/genomic tools for public health, Genetic testing, Interest, Lung cancer, Uptake
1.
Collins FS: Shattuck lecture – medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28–37.
2.
Feero WG, Guttmacher AE, Collins FS: The genome gets personal–almost. JAMA 2008;299:1351–1352.
3.
Scheuner MT, Sieverding P, Shekelle PG: Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 2008;299:1320–1334.
4.
Sheeran P: Intention-behavior relations: A conceptual and empirical review, in Stroebe W, Hewstone M (eds): European Review of Social Psychology, vol 12. Chichester, John Wiley & Sons, 2002, pp 1–36.
5.
Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT: Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 2006;15:840–855.
6.
Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:148–157.
7.
Persky S, Kaphingst KA, Condit CM, McBride CM: Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review. Genet Med 2007;9:727–738.
8.
Westmaas JL, Woicik PB: Dispositional motivations and genetic risk feedback. Addict Behav 2005;30:1524–1534.
9.
Lerman C, Croyle RT, Tercyak KP, Hamann H: Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002;70:784–797.
10.
O‘Neill SC, White DB, Sanderson SC, Lipkus IM, Bepler G, Bastian LA, McBride CM: The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genet Med 2008;10:121–130.
11.
Petty RE, Cacioppo JT: The elaboration likelihood model of persuasion, in Berkowitz L (ed): Advances in Experimental Social Psychology. New York, Academic Press, 1986, pp 123–205.
12.
Rogers RW: Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation, in Cacioppo JT, Petty RE (eds): Social Psychophysiology: A Sourcebook. New York, Guilford Press, 1983, pp 153–176.
13.
Ruiter RA, Kok G, Verplanken B, Brug J: Evoked fear and effects of appeals on attitudes to performing breast self-examination: an information-processing perspective. Health Educ Res 2001;16:307–319.
14.
Witte K, Allen M: A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav 2000;27:591–615.
15.
McBride CM, Emmons KM, Lipkus IM: Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003;18:156–170.
16.
Bratt O, Kristoffersson U, Lundgren R, Olsson H: Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997;50:360–365.
17.
Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Grönberg H: Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 2000;36:235–241.
18.
Cormier L, Valéri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, Guillemin F, Mangin P: Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 2002;51:276–285.
19.
Cowan R, Meiser B, Giles GG, Lindeman GJ, Gaff CL: The beliefs and reported and intended behaviors of unaffected men in response to their family history of prostate cancer. Genet Med 2008;10:430–438.
20.
Diefenbach MA, Schnoll RA, Miller SM, Brower L: Genetic testing for prostate cancer. Willingness and predictors of interest. Cancer Pract 2000;8:82–86.
21.
Doukas DJ, Li Y: Men’s values-based factors on prostate cancer risk genetic testing: a telephone survey. BMC Med Genet 2004;5:28.
22.
Miesfeldt S, Jones SM, Cohn W, Lippert M, Haden K, Turner BL, Martin-Fries T, Clark SM: Men’s attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 2000;55:46–50.
23.
Sanderson SC, Wardle J, Jarvis MJ, Humphries SE: Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med 2004;39:458–464.
24.
Sanderson SC, Wardle J: Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm? Genet Test 2008;12:59–66.
25.
Sanderson SC, Wardle J: Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Educ Behav 2005;32:640–653.
26.
Kasparian NA, Meiser B, Butow PN, Soames Job RF, Mann GJ: Anticipated uptake of genetic testing for familial melanoma in an Australian sample: an exploratory study. Psychooncology 2007;16:69–78.
27.
Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA: Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4:169–173.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.